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Our study demonstrated the functions of microRNA-7 (miR-7) in cervical cancer. The overexpression
of miR-7 in the cervical cancer cell lines HeLa and C-33A suppressed cell viability and promoted cell
apoptosis, whereas the inhibition of miR-7 had opposite effects. Furthermore, an oncogene, X-
linked inhibitor of apoptosis protein (XIAP), was identiﬁed as a new target of miR-7, and the ectopic
expression of XIAP rescued the effects induced by miR-7 in HeLa and C-33A cells. These results indi-
cate that miR-7 targeted and downregulated the oncogene XIAP to regulate the effect of miR-7 on
apoptosis and malignant behaviors of HeLa and C-33A cells.
 2013 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction (e.g., miR-302–367, miR-424, miR-214) [9–12] or enhancers (e.g.,MicroRNAs (miRNAs) are a group of small, non-coding RNA
molecules, approximately 19–25 nucleotides in length, that regu-
late gene expression by targeting mRNAs to trigger either transla-
tional repression or mRNA degradation [1,2]. miRNAs are involved
in cellular processes such as development, proliferation, apoptosis,
stress response, etc. [3,4]. Documented evidence has shown that
the altered expression of speciﬁc miRNA genes contributes to the
initiation and progression of cancer [2]. For instance, miR-218
[5], miR-10a [6] and miR-181b [7] acts as tumor suppressors in
medulloblastoma, hepatoma cells and gastric adenocarcinomas,
respectively. Studies on the function and mechanism of miRNAs
can be especially useful in improving cancer treatments.
Cervical cancer is the second leading cause of cancer mortality
in women worldwide [8]. Previous reports from other labs and
our lab have shown that many miRNAs are aberrantly expressed
in cervical cancer and that miRNAs can act as tumor suppressorsmiR-205, miR-21, miR-19a/b) [13–15]. Although some progress
has been achieved in the past decades, much more effort is needed
to elucidate the occurrence and mechanism of cervical cancer.
Extensive research has shown that microRNA-7 (miR-7) was
deregulated and played a tumor suppressor role in many tumors,
including hepatocellular carcinoma, lung cancer, and breast cancer,
etc. [16–18], but the role of miR-7 in cervical cancer cells remains
unclear. According to a bioinformatic prediction, X-linked inhibitor
of apoptosis protein (XIAP) is a candidate target gene of miR-7 and
has an anti-apoptotic effect, which may mediate miR-7 effection in
cervical cancer cells. Thus, we chose XIAP for further study. XIAP
has been demonstrated to be highly expressed in several malignan-
cies, including cervical cancer, and plays an important role in regu-
lating both apoptosis and cell proliferation [19–22]. The purpose of
this study was to determine the effect of miR-7 on the malignant
behaviors of cervical cancer cells and to explore the possible mech-
anisms of the XIAP gene regulation bymiR-7 in cervical cancer cells.
These ﬁndings may be useful for the development of possible ap-
proaches for cervical cancer treatment in a clinical application.
2. Materials and methods
2.1. miRNA target prediction
TargetScan, PicTar, and miRBase were used to predict the puta-
tive targets of miR-7.
2248 S. Liu et al. / FEBS Letters 587 (2013) 2247–22532.2. Cell culture and transfection
The human cervical cancer cell lines HeLa and C-33A were
maintained in RPMI1640 (Invitrogen, Carlsbad, CA) with 10%
heat-inactivated fetal bovine serum, 100 IU/ml penicillin and
100 lg/ml streptomycin in a humidiﬁed 5% (v/v) atmosphere of
CO2 at 37 C. Transfection was performed with Lipofectamine
2000 reagent (Invitrogen, Carlsbad, CA) following the manufac-
turer’s protocol.
2.3. Cervical cancer tissue, RNA preparation and quantitative RT-PCR
analysis
15 pairs of cervical cancer and adjacent normal tissues, were
obtained at the Cancer Center of Sun Yat-sen University of Medical
Science in accordance with the ethical standards of the institu-
tional committee.
Large and small RNAs from tissue were isolated with the mir-
Vana miRNA Isolation Kit (Ambion, Austin, TX, USA) according to
the manufacturer’s protocol. Total RNAs of cell lines were extracted
with Trizol reagent (Invitrogen, CA, USA) according to the manu-
facturer’s instructions. Five micrograms of an RNA sample was re-
verse transcribed to cDNA using oligo (dT) primers and M-MLV
reverse transcriptase (Promega, Madison WI); the cDNA was used
for the ampliﬁcation of XIAP and b-actin. Quantitative RT-PCR
(qRT-PCR) was performed to detect the relative transcript levels
of miR-7 and XIAP. PCR was performed under the following condi-
tions: 94 C for 4 min followed by 40 cycles of 94 C for 1 min,
56 C for 1 min and 72 C for 1 min. The relative expression levels
of the gene of interest were calculated by the 244Ct method. All
primers were synthesized by AuGCT Inc. (Beijing, China).
2.4. Plasmid construction and oligonucleotides
In this study, the following vectors were constructed: pcDNA3/
pri-miR-7, pcDNA3/enhanced green ﬂuorescence protein (EGFP)-
XIAP-30UTR, pcDNA3/EGFP-XIAP-30UTR mutant, pSIH1-H1-cop-
GFP/shRNA-XIAP (shRNA-XIAP) and pcDNA3/XIAP. All the primers
and oligonucleotides used in this work are listed in Table 1. We
also commercially synthesized a 20-O-methyl-modiﬁed antisense
oligonucleotide (ASO-miR-7) to perform miR-7 loss of function.
2.5. Western blot
Cultured cells were lysed in RIPA buffer, and lysates were ana-
lyzed by a standard western blot procedure [25]. Glyceraldehyde-Table 1
Primers and oligonucleotides used in this work.
Name Sequ
pri-miR-7-S 50-CG
pri-miR-7-AS 50-CG
ASO-miR-7 50-AC
ASO-NC 50-CA
XIAP–30UTR-top 50-AA
XIAP–30UTR-bot 50-TC
XIAP-30UTR mut-top 50-AA
XIAP-30UTR mut-bot 50-TC
XIAP-S 50-GC
XIAP-AS 50-GC
shR-XIAP-top 50-GA
shR-XIAP-bot 50-AA
b-Actin-S 50-CG
b-Actin-AS 50-CT
miR-7 RT primer 50-GT
miR-7 Forward primer 50-TG
U6 RT primer 50-GT
U6 Forward primer 50-TG
Reverse primer 50-CC3-phos-phate dehydrogenase (GAPDH) was used as an endogenous
normalizer. The anti-GAPDH antibody, anti-XIAP antibody and
horseradish peroxidase (HRP)-conjugated secondary antibody
were from Saierbio (Tianjin, China).
2.6. Fluorescent reporter assay
HeLa cells or C-33A cells were cotransfected with pcDNA3/pri-
miR-7 or ASO-miR-7 in a 48-well plate followed by the pcDNA3/
EGFP-XIAP-30UTR or pcDNA3/EGFP-XIAP-30UTR mut. pcDNA3 or
ASO-NC was used as the control group. A separate RFP expression
vector, pDsRed2-N1 (Clontech, Mountain View, CA), was used for
normalization. The cells were lysed 72 h later, and the proteins
were harvested. The EGFP and RFP ﬂuorescence intensities were
detected with the F-4500 Fluorescence Spectrophotometer (Hit-
achi, Tokyo, Japan).
2.7. Cell viability assay
Cells were seeded in 96-well plates at 6000 cells per well (HeLa
cells) or 8000 cells per well (C-33A cells), 24 h after transfection.
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bro-
mide (MTT) assay was used to determine cell viability 24, 48,
and 72 h after the cells were seeded. The absorbance at 570 nm
was measured using an lQuant Universal Microplate Spectropho-
tometer (BioTek, Winooski, VT).
2.8. Colony formation assay
Colony formation assay was performed according to the meth-
ods described previously with HeLa cells and C-33A cells [25]. Col-
ony formation was quantiﬁed using the colony formation number.
2.9. TUNEL assay
HeLa cells were transfected with pcDNA3/pri-miR-7 or ASO-
miR-7, pcDNA3/XIAP or pSIH1-H1-copGFP/shRNA-XIAP. The cells
were seeded on a 14-well slide 18–24 h after transfection. 12–
16 h after seeding, the cells were induced by 1 ppc (54 lg/ml) pac-
litaxel for 8–18 h. Cell apoptosis was detected using the In situ Cell
Death Detection Kit and Fluorescein (Roche Applied Science, IN,
USA) according to the manufacturer’s instructions. 40,6-diamidi-
no-2-phenylindole (DAPI) staining was used to determine the
number of nuclei and the total cell number.ence (50–30)
AGGATCCAAACTGCTGCCAAAACCAC-30
GAATTCGTAAATCGGACATTAGTAGAACAG-30
AACAAAAUCACUAGUCUUCCA-3’
GUACUUUUGUGUAGUACAA-3’
TTC AATATAAAATA TGTCT CAGATCTTCCAA GCTTC-3’
GAGAAGC TTGGAAGATCTGAGACATATTTTATATT G-3’
TTC AATATAAAATATGTCTCAGATGAAGGAA GCTTC-3’
GAGAAGC TTCCTTCATCTGAGACATATTTTATATT G-3’
GAATTCGCCACCATGACTTTTAACAGTTTTGAAG-30
AGCCTCGAGGCAGACATAAAAATTTTTTGCTTG-30
TCCTAGGTGAAGGTGATAAAGTAACTCGAGTTACTTTATCACCTTCACCTATTTTTG-30
TTCAAAAATAGGTGAAGGTGATAAAGTAACTCGAGTTACTTTATCACCTTCACCTAG-30
TGACATTAAGGAGAAGCTG-30
AGAAGCATTTGCGGTGGAC-30
CGTATCCAGTGCAGGGTCCGAGGTGCACTGGATACGACACAACAA-30
GAAGACTAGTGATT-30
CGTATCCAGTGCAGGGTCCGAGGTGCACTGGATACGACAAAATATGG-30
CGGGTGCTCGCTTCGGCAGC-30
AGTGCAGGGTCCGAGGT-30
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Statistical signiﬁcance was determined using Student’s t-test.
The data are expressed as the means ± S.D. A P value less than
0.05 was considered statistically signiﬁcant. All our experiments
were repeated more than three times and each experiment has tri-
ple wells. One representative experiment was selected to draw dia-
grams and data analysis.
3. Results
3.1. miR-7 affects cell viability, colony formation and apoptosis in
cervical cancer cells
To determine the effects of miR-7 in vitro, we ﬁrst used qRT-
PCR to validate the expression of miR-7 in HeLa and C-33A cells
after transfection with a miR-7 expression vector (pri-miR-7) or
miR-7 antisense oligonucleotide (ASO-miR-7). The miR-7 expres-
sion level was upregulated in cells transfected with pri-miR-7
and decreased in cells transfected with ASO-miR-7 (Fig. 1A and
B). Next, MTT, colony formation and TUNEL assays were performed
to examine the effect of miR-7 on HeLa and C-33A cells. The MTT
assay showed that upregulated miR-7 reduced cell viability,
whereas ASO-miR-7 increased cell viability in HeLa cells (Fig. 1C).
The colony formation assay showed that upregulated miR-7 re-
duced the colony formation number by approximately 40%,
whereas ASO-miR-7 increased colony formation number up to
approximately 1.5-fold in HeLa cells (Fig. 1D). Similar results were
obtained in C-33A cells (Fig. 1E and F). The TUNEL assay showed
that the upregulated miR-7 increased the paclitaxel-induced apop-
tosis in HeLa cells (Fig. 1G), but ASO-miR-7 did not signiﬁcantly
inﬂuence cell apoptosis (Fig. 1G), which may be due to the endog-
enous low expression of miR-7. These results demonstrate that
miR-7 can suppress cell growth and induce cell apoptosis in cervi-
cal cancer cells.Fig. 1. miR-7 affects cell viability and colony formation in HeLa and C-33A cells in vitro
ASO-miR-7 in HeLa and C-33A cells. U6 snRNA was used for endogenous normalization. (
viability was detected by the MTT assay at 24, 48 and 72 h (C and E). HeLa or C-33A ce
in vitro was assessed by the colony formation assay (D and F). (G) HeLa cells were transf
18 h. Fluorescein staining indicated apoptotic cells. DAPI staining was used to determ
⁄⁄P < 0.01).3.2. miR-7 binds directly to the XIAP 30UTR in cervical cancer cells
To determine the target gene that mediates the effect of miR-7
on the cervical cancer cells, TargetScan, PicTar, and miRBase were
used to predict the potential targets of miR-7. Among these genes,
XIAP (GenBank Accession NM_001167.3) was predicted as a poten-
tial target of miR-7 and selected as our target gene because of its
correlation to apoptosis resistance. We found that the 30UTR of
the XIAP mRNA contains a miR-7-complementary binding site,
which is conserved among species (Fig. 2A). EGFP reporter assays
were performed with EGFP reporter vectors carrying the XIAP
30UTR or XIAP 30UTR mut. In HeLa cells, the overexpression of
miR-7 by pri-miR-7 repressed EGFP expression by approximately
20% compared with the control vector (Fig. 2B), whereas the down-
regulation of miR-7 with ASO-miR-7 increased the intensity of
EGFP ﬂuorescence up to approximately 1.35-fold compared with
the control group (Fig. 2B). The EGFP expression in HeLa cells
transfected with XIAP 30UTR mut was not affected by the overex-
pression or knockdown of miR-7 (Fig. 2C). In addition, qRT-PCR
and western blot analysis were used to determine whether miR-
7 affects endogenous XIAP mRNA and protein levels. In HeLa cells,
qRT-PCR indicated the relative transcript levels of XIAP after trans-
fection with pri-miR-7 were downregulated by 50% compared with
the control group, but increased up to 1.4-fold after transfection
with ASO-miR-7 compared with the control group (Fig. 2D). Wes-
tern blot showed that the protein expression level of XIAP gene
was downregulated or upregulated by the overexpression or
knockdown of miR-7 in HeLa cells (Fig. 2E). Similar results were
obtained in C-33A cells (Fig. 2B–D, F). In addition, to investigate
the expression of miR-7 and XIAP in cervical cancer tissues, qRT-
PCR assays were performed on 15 pairs of cervical cancer and adja-
cent normal tissues to detect the expression of miR-7 and XIAP.
Under these conditions, the miR-7 expression level was lower
(Fig. 2G) and XIAP expression level was higher (Fig. 2H) in the tu-
mor tissues compared with the matched normal tissues, which
indicates that miR-7 and XIAP expressions levels are conversely. (A and B) The expression level of miR-7 following the transfection of pri-miR-7 or
C–F) HeLa or C-33A cells were transfected with either pri-miR-7 or ASO-miR-7. Cell
lls were transfected with either pri-miR-7 or ASO-miR-7. The cell growth capacity
ected with pri-miR-7 or ASO-miR-7 and treated with 1 ppc (54 lg/ml) paclitaxel for
ine the number of nuclei and to assess the gross cellular morphology. (⁄P < 0.05;
Fig. 2. XIAP is directly repressed by miR-7. (A) The XIAP 30UTR has a putative miR-7 binding site that is conserved in human, rhesus, mouse, rabbit and dog mRNA. Sequence
alignment of miR-7 with the wild-type and mutant (mut) 30UTR of XIAP. (B) The intensity of EGFP ﬂuorescence in HeLa and C-33A cells transfected with pri-miR-7 was
decreased after 48 h and increased following transfection with ASO-miR-7. (C) Pri-miR-7 and ASO-miR-7 had no effect on the intensity of EGFP ﬂuorescence in HeLa and
C-33A cells transfected with the 30UTR mutant vector. (D) The expression level of XIAP in HeLa and C-33A cells was signiﬁcantly altered following transfection with either pri-
miR-7 or ASO-miR-7 as determined by qRT-PCR using U6 snRNA for normalization. (E and F) The protein levels of XIAP in HeLa and C-33A cells decreased or increased
compared with the control group when miR-7 was overexpressed or blocked, respectively. (G and H) The relative expressions of miR-7 and XIAP in the 15 pairs of cervical
cancer tissues and matched normal tissues were determined with qRT-PCR. U6 snRNA or b-actin was used for normalization. (⁄P < 0.05; ⁄⁄P < 0.01).
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miR-7 directly binds to the XIAP 30UTR and speciﬁcally suppresses
the expression of XIAP.
3.3. XIAP increases cell viability, colony formation and suppresses cell
apoptosis in vitro
To examine the effect of XIAP on cervical cancer cells, we used
gain-of-function and loss-of-function assays. First, we validated
the efﬁciency of a XIAP expression vector, pcDNA3/XIAP, in HeLa
cells (Fig. 3A and B). The overexpression of XIAP enhanced cell via-
bility (Fig. 3C) and increased colony formation number up to
approximately 1.4-fold (Fig. 3D) compared with control group in
HeLa cells. In addition, we suppressed XIAP expression in HeLa
and C33A cells with a plasmid expressing a speciﬁc small interfer-
ing hairpin RNA targeting XIAP (pSIH1-H1-copGFP/shRNA-XIAP,
shR-XIAP). qRT-PCR and western blot indicated that shR-XIAP re-
duced the XIAP mRNA by approximately 43% and protein levels
by approximately 54% of the normal level in HeLa cells, respec-
tively (Fig. 3A and B). Furthermore, the inhibition of XIAP expres-sion decreased viability (Fig. 3C) and reduced colony formation
by approximately 30% (Fig. 3D) in HeLa cells compared with the
control groups. Similar results were obtained in C-33A cells
(Fig. 3E–H). The TUNEL assay showed that the knockdown of XIAP
promoted cell apoptosis and that the overexpression of XIAP sup-
pressed cell apoptosis in HeLa cells (Fig. 3I). These results demon-
strate that the effect of XIAP knockdown on cell proliferation and
apoptosis is consistent with the effect of miR-7 overexpression in
HeLa and C33A cells.
3.4. Ectopic expression of XIAP counteracts the effects of miR-7 in
cervical cancer cells
To further conﬁrm that the effects of miR-7 on the proliferation
and apoptosis of cervical carcinoma cells are mediated by XIAP,
pcDNA3/XIAP was constructed. This construct contained the cod-
ing sequence of XIAP without the 30UTR to avoid miRNA interfer-
ence. MTT (Fig. 4A and B), colony formation (Fig. 4C and D) and
western blot assays (Fig. 4E and F) showed that the ectopic expres-
sion of XIAP rescued the effects caused by miR-7 in HeLa and C-33A
Fig. 3. XIAP affects viability, colony formation and apoptosis in HeLa and C-33A cells. (A–H) The mRNA level of XIAP in HeLa cells or C-33A cells transfected with shR-XIAP or
pcDNA3/XIAP (A and E). The protein levels of XIAP in HeLa and C-33A cells was decreased or increased compared with the control group when XIAP was blocked or
overexpressed, respectively (B and F). HeLa or C-33A cells were transfected with either shR-XIAP or pcDNA3/XIAP. Cell viability was detected by the MTT assay at 24, 48 and
72 h (C and G). In HeLa and C-33A cells, the colony formation number was lower or higher compared with the control vector after transfected with either shR-XIAP or
pcDNA3/XIAP, respectively (D and H). (I) HeLa cells were transfected with shR-XIAP or pcDNA3/XIAP and treated with 1 ppc (54 lg/ml) paclitaxel for 8 h. Fluorescein staining
indicated apoptotic cells. DAPI staining was used to determine the number of nuclei and to assess the gross cellular morphology. (⁄P < 0.05; ⁄⁄P < 0.01). (In the ﬁgure, the
pcDNA3/XIAP plasmid was represented by XIAP).
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sion of XIAP could counteract the effect of miR-7 on HeLa cell
apoptosis. These results show that miR-7 suppresses cell viability
and colony formation and promotes apoptosis by downregulating
XIAP expression in cervical carcinoma cells.
4. Discussion
In recent decades, a number of miRNAs have been found and
shown to play important roles in gene expression regulation
through the alteration of mRNAs or translation [23,24]. Many stud-
ies have shown that miRNAs may function as either tumorigenic or
tumor-suppressing genes [25,26]. In our study, we found that in
cervical cancer cells, miR-7 suppressed cell viability, colony forma-tion and promoted apoptosis in cervical cancer cells through
downregulating the expression of XIAP by targeting the 30UTR of
XIAP. In Fig. 1G, ASO-miR-7 did not signiﬁcantly affect cell apopto-
sis in HeLa cells; this is possibly due to a low expression level of
miR-7 in cervical cancer cells. The low expression of miR-7 in cer-
vical cancer tissues compared with the adjacent non-tumor tissue
(Fig. 2G and H) support this notion.
XIAP is involved in regulating a number of functions [27]. Re-
ports showed that XIAP was overexpressed in several classes of
cancer [28] and suppressed apoptosis [29]. Our results were con-
sistent with this. Biological prediction and the apoptosis resistance
function of XIAP in many tumors helped identify XIAP as target
gene of miR-7 [19–22]. In our study, the loss of XIAP function
showed growth suppression and apoptosis promotion in HeLa
Fig. 4. XIAP rescues miR-7-induced cellular phenotypes in cervical cancer cells. HeLa cells or C-33A cells were co-transfected with the pcDNA3/XIAP vector, which did not
contain the 3’-UTR of XIAP, with or without the pri-miR-7 vector. (A and B) Cell viability was detected by the MTT assay at 24, 48 and 72 h after transfection. (C and D) A
colony formation assay was performed after transfection. (E and F) The XIAP protein level was measured by western blot 48 h after transfection. (G) The 1 ppc (54 lg/ml)
paclitaxel-induced apoptosis of HeLa cells for 12 h was determined by TUNEL assays. (⁄P < 0.05; ⁄⁄P < 0.01).
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expression. The XIAP gain-of-function assay showed growth pro-
motion and apoptosis suppression in HeLa and C-33A cells,
which is consistent with the results of miR-7 knockdown. Ectopic
expression of XIAP rescued the effects caused by miR-7. Thus, a
series of results support the hypothesis that miR-7 functions in
cervical cancer cells by targeting the 30UTR of XIAP.
In summary, our study shows that miR-7 functions as a tumor
suppressor gene and further extends the biological role of miR-7
in HeLa and C-33A cells. For the ﬁrst time, we identify XIAP as a
new target that is possibly involved in miR-7-mediated growth
suppression and apoptosis induction of cervical cancer cells. These
ﬁndings may provide a basic rationale for the application of miR-7
in the treatment of cervical cancer.
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